Cargando…

Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction

BACKGROUND: Indications for the primary prevention of sudden death using an implantable cardioverter defibrillator (ICD) are based predominantly on left ventricular ejection fraction (LVEF). However, right ventricular ejection fraction (RVEF) is also a known prognostic factor in a variety of structu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jimenez-Juan, Laura, Karur, Gauri R., Connelly, Kim A., Deva, Djeven, Yan, Raymond T., Wald, Rachel M., Singh, Sheldon, Leung, General, Oikonomou, Anastasia, Dorian, Paul, Angaran, Paul, Yan, Andrew T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388044/ https://www.ncbi.nlm.nih.gov/pubmed/28416981 http://dx.doi.org/10.1016/j.joa.2016.07.005

Ejemplares similares

Prognostic value of cardiovascular magnetic resonance left ventricular volumetry and geometry in patients receiving an implantable cardioverter defibrillator
por: Urzua Fresno, Camila M., et al.
Publicado: (2021)

Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy
por: Chacko, Binita Riya, et al.
Publicado: (2018)

Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
por: Rizzello, Vittoria
Publicado: (2022)

Myocardial strain assessment using cardiovascular magnetic resonance imaging in recipients of implantable cardioverter defibrillators
por: Tan, Nigel S., et al.
Publicado: (2021)

Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35%
por: Wasfy, Jason H, et al.
Publicado: (2023)

Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device
por: Zormpas, Christos, et al.
Publicado: (2020)

Absence of left bundle branch block and blood urea nitrogen predict improvement in left ventricular ejection fraction in patients with cardiomyopathy and wearable cardioverter defibrillators
por: Mehta, Nikhil A., et al.
Publicado: (2019)

Rate of Recovery of Left Ventricular Ejection Fraction in a Real-World Population of Patients Receiving a Wearable Cardioverter Defibrillator
por: Abney, Lon, et al.
Publicado: (2021)

Does defibrillation threshold increase as left ventricular ejection fraction decreases?
por: Val-Mejias, Jesus E., et al.
Publicado: (2010)

De novo subcutaneous implantable cardioverter-defibrillator in patient with left ventricular assist device
por: Reichert, William, et al.
Publicado: (2020)

Emerging electromagnetic interferences between implantable cardioverter-defibrillators and left ventricular assist devices
por: Yalcin, Yunus C, et al.
Publicado: (2020)

Subcutaneous implantable cardioverter‐defibrillator noise following left ventricular assist device implantation
por: Khetarpal, Banveet Kaur, et al.
Publicado: (2023)

Implantable cardioverter defibrillator as a treatment for massive left ventricular fibroma-induced ventricular arrhythmia in a child
por: Choi, In Su, et al.
Publicado: (2021)

Determinants of Left Ventricular Characteristics Assessed by Cardiac Magnetic Resonance Imaging and Cardiovascular Biomarkers Related to Kidney Transplantation
por: Prasad, G. V. Ramesh, et al.
Publicado: (2018)

Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators
por: Kawamura, Mitsuharu, et al.
Publicado: (2019)

Double valve replacement in a patient with implantable cardioverter defibrillator with severe left ventricular dysfunction
por: Manjunath, Girish, et al.
Publicado: (2016)

Premature end of service of implantable cardioverter-defibrillator by magnetic interference with left-ventricular assist device
por: Eiringhaus, Jörg, et al.
Publicado: (2021)

Interaction between electrical storm and left ventricular ejection fraction as predictors of mortality in patients with implantable cardioverter defibrillator: A Chinese cohort study
por: Zhai, Zhengqin, et al.
Publicado: (2022)

Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction
por: Judson, Gregory L., et al.
Publicado: (2022)

Cardiovascular magnetic resonance left ventricular strain in end-stage renal disease patients after kidney transplantation
por: Gong, Inna Y., et al.
Publicado: (2018)

Additional left ventricular septal lead facilitates R-wave sensing of implantable cardioverter-defibrillator in arrhythmogenic right ventricular cardiomyopathy: a case report
por: Lu, Wenzhao, et al.
Publicado: (2023)

Left ventricle remodeling predicts the recurrence of ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients for secondary prevention
por: Lee, Wei-Chieh, et al.
Publicado: (2016)

Prospective Randomized Evaluation of Implantable Cardioverter‐Defibrillator Programming in Patients With a Left Ventricular Assist Device
por: Richardson, Travis D., et al.
Publicado: (2018)

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device
por: Murphy, Michele, et al.
Publicado: (2016)

Subcutaneous implantable cardioverter defibrillators in patients with left ventricular assist devices: case report and comprehensive review
por: López-Gil, María, et al.
Publicado: (2019)

Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view
por: Disertori, Marcello, et al.
Publicado: (2016)

Successful Treatment of an Infant with Left Ventricular Noncompaction Presenting with Fatal Ventricular Arrhythmia Treated with Cardiac Resynchronization Therapy and an Implantable Cardioverter Defibrillator
por: Kimura, Masato, et al.
Publicado: (2018)

Relationship between MRI derived right ventricular mass and left ventricular involvement in patients with anderson-fabry disease
por: Li, Qin, et al.
Publicado: (2015)

Impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for implantable cardioverter defibrillators
por: Joshi, Subodh B, et al.
Publicado: (2011)

Implantable cardioverter defibrillator implantation and degree of left ventricular scarring predict survival in patients with severe ischemic cardiomyopathy
por: Kwon, Deboarh H, et al.
Publicado: (2011)

Influence of a fully magnetically levitated left ventricular assist device on functional interrogation of implantable cardioverter defibrillators
por: Schukro, Christoph, et al.
Publicado: (2019)

Implantable Cardioverter-defibrillator Therapy in the Patient with a Left Ventricular Assist Device: Still a Black Box
por: Richardson, Travis, et al.
Publicado: (2017)

Interaction between the left ventricular ejection fraction and left ventricular strain and its relationship with coronary stenosis
por: Gui, Hai-Yan, et al.
Publicado: (2023)

Short axis versus axial Cine SSFP MR imaging for assessment of right and left ventricular function: intrapatient correlation with phase-contrast flow measurements
por: James, Susan H, et al.
Publicado: (2011)

Erratum: Relationship between MRI derived right ventricular mass and left ventricular involvement in patients with anderson-fabry disease
por: Ng, Ming-Yen, et al.
Publicado: (2015)

Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation
por: Joshi, Subodh B, et al.
Publicado: (2012)

Effects of renal denervation therapy on cardiac function and malignant arrhythmia in patients with reduced left ventricular ejection fraction and narrow QRS complexes treated with implantable cardioverter defibrillator
por: Yang, Wei, et al.
Publicado: (2022)

Implantable Cardioverter Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices: Utilization Patterns, Related Procedures, and Complications
por: Alvarez, Paulino A., et al.
Publicado: (2019)

Combined etiology of anaphylactic cardiogenic shock: Amiodarone, epinephrine, cardioverter defibrillator, left ventricular assist devices and the Kounis syndrome
por: Kounis, Nicholas G., et al.
Publicado: (2015)

Prognostic impact of implantable cardioverter defibrillators and associated adverse events in patients with continuous flow left ventricular assist devices
por: Pausch, Jonas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ffqssk7ic6jvf57p96c24eaf0m